BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd. - Candlesense
BWAY Mergers

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home

Related Questions

How will BrainsWay's investment in Neurolief influence its short‑term earnings guidance and stock valuation? What is the size and growth rate of the at‑home neuromodulation mental‑health market, and how does BrainsWay's offering compare to existing competitors? What regulatory, reimbursement, or adoption challenges could affect the rollout of home‑based neuromodulation therapies and impact the stock's upside?
Find similar articles on Candlesense globenewswire